Mr Jay Bhimani > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices

Three Bryant Park, 1095 Avenue of the Americas
NY 10036-6797
United States
- Firm Profile
- Go to...
Mr Jay Bhimani

Work Department
Product Liability and Mass Torts
Position
Partner
Career
Jay Bhimani counsels clients on a range of commercial litigation matters, with a focus on product liability and mass torts. Mr. Bhimani advises clients across a range of industries and has served as counsel in some of the nation’s most significant recent disputes, including as trial counsel to a major multinational corporation in litigation related to the company’s talcum powder products. His trial work has resulted in defense verdicts selected as among the “Top Verdicts” in 2018 and 2019 (Daily Journal), the “Top Product Liability cases of 2018” (Law360), and the “Top 10 Most Impressive Defense Verdicts” in 2019 (Courtroom View Network).
In addition, Mr. Bhimani serves as counsel for a product manufacturer in a multi-district litigation involving hearing loss claims by service members related to a product sold to the military.
Mr. Bhimani also has substantial experience in the field of securities litigation. He has served as counsel in securities actions in which plaintiffs sought many billions of dollars in damages, including in the country’s largest private insider trading action and several residential mortgage-backed securities actions brought by a government agency arising out of the 2008 financial crisis.
Pro bono activities are also a significant part of Mr. Bhimani’s practice. In 2016, Public Counsel’s Consumer Law Project awarded Mr. Bhimani its 2016 Public Counsel Pro Bono Award.
Languages
- English
- Gujarati
Education
- University of California, Los Angeles, B.A., 2006, magna cum laude, College Honors
- University of California, Los Angeles School of Law, J.D., 2009
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Dechert LLP has secured favorable outcomes for pharma and medical device clients in appellate, federal, and state courts, handling complex multi-district and state-court product liability litigations. Notably, the firm has achieved significant victories through persuasive dispositive motions, often reducing or eliminating plaintiff pools. The product liability and mass torts practice is co-chaired by Los Angeles’ Jay Bhimani, an experienced trial lawyer, including in high-stakes bellwether cases. New York-based co-chair Douglas E. Fleming III’s extensive litigation experience includes examining and preparing witnesses for deposition, Daubert hearings, and trial and legislative testimony. New York-based Mark Cheffo, who co-chairs the global litigation practice, leads complex, high-profile pharma litigations, managing all stages from negotiation, through pre-trial proceedings to trial. Cheffo has been a key figure in the firm’s representation of GlaxoSmithKline as lead national counsel in the Zantac mass tort litigation. Also in New York, special counsel Sheila L. Birnbaum has vast experience representing leading pharma companies in complex product liability and mass torts litigation.
United States > Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
Dechert LLP fields a dedicated team of product liability and mass tort specialists that have achieved success before the appellate, federal and state courts in multi-district and state-court litigations for clients in the chemicals, manufacturing and life sciences sectors. Mark S. Cheffo is experienced in serving as national coordinating and trial counsel in product liability, as well as in toxic and environmental exposure suits. Douglas E. Fleming III represents clients in numerous industries including the chemical, pharmaceutical and medical device industries, with his expertise covering both trail and appellate levels throughout the United States. Hayden Coleman is experienced in litigating federal and state multidistrict litigation, class actions and government actions In Los Angeles, Jay Bhimani has served as trial counsel in a range of federal multi-district litigation. Marina Schwarz and Los Angeles situated Allie Ozurovich are key names.
United States > Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
Praised by clients for going ‘above and beyond in terms of responsiveness’, Dechert LLP’s product liability and mass torts practice continues to represent and defend high-profile clients in complex multidistrict and state court litigation. across a range of industries, including pharmaceuticals, consumer goods, manufacturing, and insurance. The team has secured key victories for clients such as such as GlaxoSmithKline (GSK), Haleon, and Microsoft. The firm serves as lead national counsel for GSK in a nationally significant multidistrict litigation concerning allegations that GSK’s heartburn medication causes cancer, and also represents the plastics manufacturing firm Saint-Gobain in high-profile civil and regulatory matters involving PFOA contamination, defending actions across multiple states.Working out of New York, Mark S. Cheffo, co-chair of the global litigation practice, brings extensive experience as national trial counsel in product liability and mass tort cases. LA based Jay Bhimani, co-chair of the product liability practice, has served as trial counsel in high-stakes matters, focusing on causation and bellwether trials.
Lawyer Rankings
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- Product liability, mass tort and class action - defense: toxic tort United States > Dispute resolution
- Product liability, mass tort and class action - defense: consumer products (including tobacco) United States > Dispute resolution
Top Tier Firm Rankings
- Environment > Environment: transactional
- Dispute resolution > International arbitration
- International trade and national security > Customs, export controls and economic sanctions
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- International trade and national security > Customs, export controls and economic sanctions
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Healthcare > Life sciences
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending > Advice to direct lenders/private credit
- Dispute resolution > E-discovery
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)